Medication Intake, Perceived Barriers, and Their Correlates Among Adults With Type 1 and Type 2 Diabetes: Results From Diabetes MILES - The Netherlands

The purpose of this study is to investigate medication intake, perceived barriers and their correlates in adults with type 1 or type 2 diabetes. In this cross-sectional study, 3,383 Dutch adults with diabetes (42% type 1; 58% type 2) completed the 12-item 'Adherence Starts with Knowledge'...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in clinical diabetes and healthcare (online) Vol. 2; p. 645609
Main Authors Hogervorst, Stijn, Adriaanse, Marce C, Hugtenburg, Jacqueline G, Bot, Mariska, Speight, Jane, Pouwer, Frans, Nefs, Giesje
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 30.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study is to investigate medication intake, perceived barriers and their correlates in adults with type 1 or type 2 diabetes. In this cross-sectional study, 3,383 Dutch adults with diabetes (42% type 1; 58% type 2) completed the 12-item 'Adherence Starts with Knowledge' questionnaire (ASK-12; total score range: 12-60) and reported socio-demographics, clinical and psychological characteristics and health behaviors. Univariable and multivariable logistic regression analyses were used. Adults with type 1 diabetes had a slightly lower mean ASK-12 score (i.e. more optimal medication intake and fewer perceived barriers) than adults with non-insulin-treated type 2 diabetes. After adjustment for covariates, correlates with suboptimal intake and barriers were fewer severe hypoglycemic events and more depressive symptoms and diabetes-specific distress. In type 2 diabetes, correlates were longer diabetes duration, more depressive symptoms and diabetes-specific distress. Adults with type 1 diabetes showed slightly more optimal medication intake and fewer perceived barriers than adults with non-insulin treated type 2 diabetes. Correlates differed only slightly between diabetes types. The strong association with depressive symptoms and diabetes-specific distress in both diabetes types warrants attention, as improving these outcomes in some people with diabetes might indirectly improve medication intake.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Dominic Ehrmann, Research Institute of the Diabetes Academy Mergentheim (FIDAM), Germany; Emma Berry, Queen’s University Belfast, United Kingdom
Edited by: Frank Jan Snoek, Academic Medical Center, Netherlands
This article was submitted to Diabetes Self-Management, a section of the journal Frontiers in Clinical Diabetes and Healthcare
ISSN:2673-6616
2673-6616
DOI:10.3389/fcdhc.2021.645609